These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Embolic protection device use and its association with procedural safety and long-term outcomes following saphenous vein graft intervention: An analysis from the British Columbia Cardiac registry. Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD; Catheter Cardiovasc Interv; 2016 Jul; 88(1):73-83. PubMed ID: 26482020 [TBL] [Abstract][Full Text] [Related]
24. "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. Fischell TA; Subraya RG; Ashraf K; Perry B; Haller S J Invasive Cardiol; 2007 Feb; 19(2):58-62. PubMed ID: 17268038 [TBL] [Abstract][Full Text] [Related]
26. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Okabe T; Lindsay J; Torguson R; Steinberg DH; Roy P; Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2008 Nov; 72(6):799-803. PubMed ID: 19006243 [TBL] [Abstract][Full Text] [Related]
27. Embolic protection: the FilterWire EZ Embolic Protection System. Patel S; Hermiller J Expert Rev Med Devices; 2008 Jan; 5(1):19-24. PubMed ID: 18095892 [TBL] [Abstract][Full Text] [Related]
28. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. Blackman DJ; Choudhury RP; Banning AP; Channon KM J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208 [TBL] [Abstract][Full Text] [Related]
29. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563 [TBL] [Abstract][Full Text] [Related]
30. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. van Gaal WJ; Choudhury RP; Porto I; Channon K; Banning A; Dzavik V; Ramsamujh R; Bui S; Blackman DJ Am J Cardiol; 2007 Mar; 99(5):603-6. PubMed ID: 17317357 [TBL] [Abstract][Full Text] [Related]
31. Export aspiration catheter-enhanced FilterWire delivery: an innovative strategy for treatment of saphenous vein graft disease. Jim MH; Ho HH; Chow WH J Invasive Cardiol; 2006 Nov; 18(11):569-74. PubMed ID: 17090825 [TBL] [Abstract][Full Text] [Related]
32. Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device. Porto I; Choudhury RP; Pillay P; Burzotta F; Trani C; Niccoli G; Blackman DJ; Channon KM; Banning AP Int J Cardiol; 2006 Apr; 109(1):53-8. PubMed ID: 16084611 [TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention. Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310 [TBL] [Abstract][Full Text] [Related]
34. Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device. Porto I; Belloni F; Niccoli G; Larosa C; Leone AM; Burzotta F; Trani C; De Maria GL; Hamilton-Craig C; Crea F EuroIntervention; 2011 Dec; 7(8):955-61. PubMed ID: 22157481 [TBL] [Abstract][Full Text] [Related]
35. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). Naidu SS; Turco MA; Mauri L; Coolong A; Popma JJ; Kereiakes DJ Am J Cardiol; 2010 Apr; 105(8):1060-4. PubMed ID: 20381653 [TBL] [Abstract][Full Text] [Related]
36. The Perils of Buddy Wire Use With a Filterwire. Gutierrez A; Chugh Y; Kostantinis S; Brilakis ES Cardiovasc Revasc Med; 2022 Jul; 40S():214-217. PubMed ID: 35086774 [TBL] [Abstract][Full Text] [Related]
37. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Coolong A; Baim DS; Kuntz RE; O'Malley AJ; Marulkar S; Cutlip DE; Popma JJ; Mauri L Circulation; 2008 Feb; 117(6):790-7. PubMed ID: 18212287 [TBL] [Abstract][Full Text] [Related]
38. Percutaneous coronary intervention in two occluded arms of a saphenous 'Y'-graft: the importance of protecting both of your arms. Chan RS; Duong MH; Kaplan AV Catheter Cardiovasc Interv; 2007 Sep; 70(3):374-8. PubMed ID: 17421014 [TBL] [Abstract][Full Text] [Related]
39. Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience. Golwala H; Hawkins BM; Stavrakis S; Abu-Fadel MS J Invasive Cardiol; 2012 Jan; 24(1):1-3. PubMed ID: 22210580 [TBL] [Abstract][Full Text] [Related]
40. A novel, low-profile filter-wire (Interceptor) embolic protection device during saphenous vein graft stenting. Young JJ; Kereiakes DJ; Rabinowitz AC; Ammar R; Boucher FL; Rogers C Am J Cardiol; 2005 Feb; 95(4):511-4. PubMed ID: 15695142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]